Introduction
Tobacco smoke is considered as one of the major causative factors in cancer of the respiratory tract (1) . One of the primary targets for tobacco smoke genotoxicity is the larynx. A strong association between tobacco smoking and larynx cancer morbidity has been proven in a number of epidemiological studies (2) (3) (4) (5) (6) . In contrast to most European countries, the incidence of larynx cancer has increased in Poland in the years 1963-1989(7,8) .
Tobacco smoke contains an abundance of carcinogenic compounds capable of interacting with DNA to form adducts. These carcinogenic compounds include polycyclic aromatic hydrocarbons (PAH*), aromatic amines and A'-nitrosoamines (1) . Studies on DNA adducts in relation to tobacco smoking have focused mostly on aromatic carcinogens (9, 10) . Less attention has been paid to A'-nitrosoamines, such as 4-(methylnitrosoamino)-l-(3-pyridyl)-l-butanone, which is metabolized
•Abbreviations: PAH, polycyclic aromatic hydrocarbons; AF, ammonium formate; PEI, polyethyleneimine; 7-me-dGMP, A/7-methyldeoxyguanosine 3'-monophosphate.
to methylating intermediates (11) (12) (13) . Methyl groups are located predominantly on the Nl and O 6 positions of guanine and on the AG position of adenine (14, 15) . The methylated DNA adducts and apurinic sites not removed by DNA repair induce mutations, but there is less evidence for procarcinogenic potency of A7-alkylguanine and apurine sites than of C^-methylguanine (16, 17) . It is necessary to point out that some authors (18) claim that most mutations in post-meiotic cells are caused by A7-alkylation rather than C^-methylguanine, because of efficient repair of the latter adduct (18, 19) .
The presence of A/7-alkylguanine in DNA in relation to tobacco smoking was demonstrated recently in blood (20) and in bronchial (21) cells of healthy and cancer subjects by the 32 P-post-labelling assay (22) , adapted to analysis of small alkylated DNA adducts (23, 24) . The aim of the present work was to extend this study to alkylated DNA adducts in the upper respiratory tract of cancer subjects. We also wanted to compare the patterns of A^-alkylguanine with aromatic DNA adducts in larynx samples of the same subjects described recently (25) .
Materials and methods

Study subjects
The subjects were patients hospitalized for tumours localized in the upper part of the larynx. The tumours were recognized as primary, including five subjects with a relapse classified as recurrent primary larynx tumours. All the tumours were diagnosed as squamous carcinoma. Treatment did not include chemo-or radiotherapy before surgery, except in the five relapse patients, who had been Co^-irradiated after the first surgery. The group consisted of 39 men aged 41-74 years (mean 56.9) and seven women aged 43-52 years (mean 47.7), all without reported occupational exposure to A'-nitrosoamines. The majority of the group were farmers. The subjects were asked about their smoking habits and alcohol consumption. The male group consisted of one non-smoker, three ex-smokers who had stopped smoking 5, 10 and 30 years before the operation and 35 smokers. The group of tobacco users was further divided into moderate (~20 cigarettes/day, 29 men) and heavy (5*40 cigarettes/ day, 6 men) smokers. Four women were moderate smokers, one a non-smoker and two ex-smokers (cessation of smoking I and 5 years before surgery). Nine of the above cancer subjects were donors of blood used for the analysis of DNA adducts in blood leucocytes. Non-cancer patients of the otolaryngology clinic (occupational contact with A'-nitrosoamines excluded) were donors of the blood used as a control. The control group consisted of 10 smokers (control I) and five non-smokers (control II) All the subjects were from the same region of Poland.
Sample collection
Tumours were removed surgically by total or partial laryngectomy. Biopsies were divided onto tumour proper and the surrounding tissue, histopathologically recognized as non-malignant. PeripheraJ blood (10 ml) was drawn into heparinized tubes and leucocytes were separated by lysing red cells. In the case of solid tissues DNA isolation was started from tissue dissection. A cell suspension was treated twice with 0.5% Triton X-100 and the nuclei were collected by centrifugation at 1000 g for 5 min. DNA was then isolated from nuclei by RNase A (Sigma) and proteinase K (Sigma) digestion followed by extraction with phenol/chloroform/isoamyl alcohol and ethanol precipitation as described by Phillips el al. (26) .
DNA adduct analysis
A^-Alkylguanine residues were analysed by a variant of the 32 P-post-labelling assay (23, 24) . modified further by Kumar et al. (27) . Coded DNA samples (5 |ig) were vacuum dried and digested first by micrococca] nuclease (Sigma) (37°C, 2 h) followed by spleen phosphodiesterase (Boehringer) (37°C, 2 h).
K.Szyfter et aL
For adduct enrichment the DNA digest was applied to a SAX anion exchange column (I cm) equilibrated with 5 ml 1 mM ammonium formate (AF). The sample eluted with 2 ml 10 mM AF, pH 5.3, was vacuum dried, dissolved in 'P < 0.05 as compared with leucocytes. b P < 0.01 male as compared with female in corresponding tissues.
1 |il Millipore-filtered water and mixed with phosphorylation mixture (1 |il) containing T4 polynucleotide kinase (US Biochemical) as described (24) . The reaction mixture was digested with PI nuclease (Boehringer) in the presence of Zn 2+ at pH 5.5, adjusted with 1% formic acid (37°C, 15 min) The samples were applied to polyethyleneimine (PEI)-cellulose TLC plates (10X10 cm; Machery Nagel), developed in the first direction in 450 mM AF, pH 5.3, dried and developed again in the second direction in 25 mM AF, pH 5.3, containing 0.5 M urea. Synthetic /V7-methyldeoxyguanosine 3'-monophosphate (7-medGMP) was concurrently analysed as a standard to calculate recovery (20, 23) . The radioactive spots were visualized on Kodak X-omat films by overnight autoradiography at room temperature. Adduct level was determined by excising the spots from autoradiographs and counting in a Cerenkov counter. The blank area of each TLC plate of a size corresponding to the spot containing W7-alkylguanine was excised to calculate background radioactivity.
Statistical analysis
Student's /-test for unequal variances was used to calculate the statistical differences between (Pearson correlation and significance) the means. Curve fitting was calculated by multiple linear regression analysis.
Results
Adjustment of the post-labelling assay for 7-me-dGMP
Adducts were purified from unmodified nucleotides using an anion exchange column eluted with AF. AF was tested in concentrations ranging from 1 to 100 mM, pH 5.3, containing methanol at up to 30%. It was found that elution of 7-medGMP was facilitated by increasing the ionic strength of the eluent. On the other hand, high ionic strength buffers (100 mM AF) eluted normal nucleotides, causing a relatively high background radioactivity spread on TLC plates. The low ionic strength buffer (1 mM AF) required a much larger elution volume and 7-me-dGMP recovery was not satisfactory. The recovery of 7-me-dGMP eluted with 2 ml 10 mM AF ranged from 35 to 39% in particular experiments. Application of methanol did not contribute appreciably to better recovery. Hence it was decided to use 10 mM AF, pH 5.3, as the optimal eluent. The 32 P-post-labelling reaction was followed by PI nuclease digestion. This step converted nucleoside 3',5'-diphosphates into 5'-monophosphates. The additional PI digestion, together with the changes in development of the chromatographic systems, allowed for clear separation of the 7-me-dGMP spot from the rest of the radioactive material ( Figure I ). Together the introduced changes made possible a reduction in the amount of alkylated DNA required for adduct analysis from 15 to 5 (ig. Each particular sample was analysed at least two (usually three) times The differences within particular samples did not exceed 20-25%. The numbers indicate average /V7-alkylguanine (±SD) content per 10 7 nucleotides. n.d., not detectable.
Tobacco smoke-associated /V7-alkylguanine N7-alkylguanine in DNA from larynx tumour subjects The average levels of A/7-alkylguanine are given in Table I . The highest average levels of A7-alkylguanine adducts were found in larynx tumour tissue (26.2/10 7 nucleotides), followed by larynx non-tumour tissue (22.7/10 7 ) and blood leucocytes (13.1/10 7 ). The difference between means for larynx rumour and non-tumour tissue was not statistically significant (P = 0.30), in contrast to significant differences between means in tumours and leucocytes (P = 0.02) and non-tumour tissue and leucocytes (P = 0.01). The level of A/7-alkylguanine in blood leucocytes of cancer subjects (mainly smokers) was somewhat higher than that in non-cancer subjects (smokers only). The large standard deviations calculated for almost all the groups listed in Table I reflect considerable inter-individual differences. The highest levels of iV7-alkylguanine content in larynx tissues exceeded the lowest ones by up to 97-fold. The variability within leucocyte DNA was much less pronounced, at up to 3.5-fold.
Substantial differences were detected between average levels of A^7-alkylguanine in DNA of males and females (Table I ). The difference between mean values of /W-alkylguanine content in larynx tissues between males and females was significant for tumours (P = 0.002), but not for non-tumour tissue (P = 0.17).
The effect of tobacco smoking on formation of N7-alkylguanine in DNA
To demonstrate the influence of tobacco smoking on Nlalkylguanine content in the diseased subjects the study group was divided into non-and ex-smokers taken together, moderate smokers (~20 cigarettes/day) and heavy smokers (5=40 cigarettes/day). The level of N7-alkylguanine in the tumour tissue (Table II) of heavy smokers exceeded that in moderate smokers almost 2.5-fold and that in non-and ex-smokers almost 6-fold. A similar but slightly less pronounced difference was observed in non-tumour larynx cells. When only males were compared the absolute values were higher, but the differences remained similar to that noted for the whole group (Figure 2 ). The differences between mean values for non-+ ex-smokers and moderate smokers were significant (P < 0.05) in tumour and non-tumour larynx tissue in the whole study group and in male subjects. The differences between mean values for moderate and heavy smokers were not significant in tumour or in non-tumour larynx tissue. However, in non-tumour larynx tissue (whole group, P = 0.086; males, P = 0.089) the differences did not greatly exceed the significance level, in contrast to larynx tumour tissue (whole group, P = 0.208; males, P = 0.219). Altogether, the data indicate that the observed correlation is clearer in larynx non-tumour tissue than in tumours. It is worth pointing out that the highest individual result was detected for a subject known to be a heavy smoker and an alcoholic (larynx tumour, 224/10 7 ; larynx non-tumour tissue, 65/10 7 ). 
Relation between N7-alkylguanine level and subject age
The correlation between A'7-alkylguanine levels in larynx tissue and subject age was analysed for the whole group. In non-tumour tissue no correlation was noted. However, in tumour tissue an increase in adduct level with subject age was observed, as shown by a Pearson correlation of 0.36 (f < 0.05) and multiple linear regression analysis (r = 0.185). The line of best fit is expressed by the equation y = 0.60* -7.25 for the whole group (Figure 3) , where y is the number of Nlalkylguanine residues per 10 7 normal nucleotides and x is subject age (years). To eliminate the influence of factors such as extent of tobacco smoking, sex or cancer progression only male subjects who were moderate smokers with primary larynx cancer were considered. However, the statistical parameters remained almost the same (r = 0.119, Pearson correlation 0.32, P < 0.05) as compared with the whole group. The linear increase in A'7-alkylguanine residues with subject age was more clearly demonstrated for leucocyte DNA (Pearson correlation 0.64, P < 0.05) for both groups but the number of samples analysed was restricted to eight (whole group) and seven (male moderate smokers).
Relationship between patterns of aromatic DNA adducts and N7-alkylguanine
The present analysis of A'7-alkylguanine was performed on the same DNA samples as an analysis of aromatic DNA adducts described previously (25) . The individual results of quantitation of A'7-alkylguanine and aromatic DNA adducts in larynx tissue are plotted against each other in Figure 4 . The results have been compared statistically. Pearson correlation coefficients calculated for larynx cancer subjects were 0.28 and 0.30 for tumour (P < 0.05) and non-tumour (P < 0.05) larynx tissues respectively. Restriction of the study group to male moderate smokers with primary tumours did not significantly alter the correlation parameters. Hence, it must be concluded that formation and removal of aromatic DNA adducts, derived primarily from PAH, and A^-alkylguanines, originating from A'-nitrosoamines, proceed independently.
Discussion
A causative role of tobacco smoking in larynx cancer has been clearly demonstrated in a number of well-documented epidemiological studies (1) (2) (3) (4) (5) (6) (7) (8) . Most studies on DNA adducts have focused on PAH and other aromatic compounds (9, 10) , considering the significance of DNA methylation in carcinogenesis (11, 12, 15) . Tobacco-specific A'-nitrosoamines are of particular importance (13, 28) . This bias may partially be due to a lack of methods to study small DNA adducts until recently. The 32 P-post-labelling assay for quantitation of Nlalkylguanine adducts required substantial revision of an assay originally designed for the analysis of aromatic bulky DNA adducts (22, 29, 30) . For small polar adducts such as 7-medGMP adduct enrichment and TLC separation require different techniques to aromatic DNA adducts (23, 24, 27, (31) (32) (33) .
We have shown with standard 7-me-dGMP and depurination experiments that the TLC spot taken as the A'7-alkylguanine adduct contains the true DNA rather than RNA adduct (23, 24, 27) . The spot also contains 7-(2-hydroxyethyl)guanine and probably also other simple alkylguanines, but due to low labelling efficiency of these adducts they are unlikely to be large contributors to adduct radioactivity (20) . Also, as our DNA purification started from nuclei, RNA contamination was likely to be low (31). The A'7-alkylguanine level established for leucocytes from healthy subjects was comparable with that found by the 32 P-post-labelling technique in white blood cells (20, 32) . In one post-labelling study no A'7-alkylguanine adducts were detected (34) . On the other hand, the level of Nlmethylguanine in white blood cells of cancer patients before chemotherapy determined by EL1SA was 6-to 12-fold higher than that found by the 32 P-post-labelling technique (23) and was further increased after treatment with dacarbazine (35) .
The data presented here are the first demonstration of tobacco smoke-derived methylated DNA adducts in the larynx of cancer subjects. An ability of laryngeal tissue to activate procarcinogens and to form aromatic DNA adducts has been shown (36, 37) . As far as we know, the only other parts of the respiratory tracts where A'7-alkylguanine adducts have been discovered are bronchus (21) and lung (32) cells. The higher A'7-alkylguanine content in non-tumour larynx tissue (range 8.3-36.3/10 7 , depending on sex and smoking habit; average, 22.7/10 7 ) than in the bronchus (range 4.7-17.3/10 7 , depending on smoking habit) could be explained by more direct exposure to tobacco smoke of the larynx than the bronchus. This explanation is supported by an analogous finding concerning aromatic DNA adducts in both these tissues. The average levels of aromatic DNA adducts found in non-tumour larynx tissue for various groups ranged from 4.8 to 6.7/10 8 (25), whereas measurements in bronchial cells covered the range 3.5-5.4/10 8 (26).
The levels of A'7-alkylguanine were found to be higher in larynx tumour cells than in non-tumour tissue, reminiscent of the aromatic DNA adduct distribution already described (25) . Comparative analysis of DNA adduct levels in normal and neoplastic target tissues has been performed in a few cases only. In contrast to our results, Van Schooten et al. (38) , studying lung tissue, noticed a strong diagonal zone representing PAH-DNA adducts in non-tumorous specimens that was almost absent in tumorous tissue. On the other hand, the percentage of cells positive for O 6 -and A7-methylguanine antibodies was 2-to 5-fold higher in preneoplastic and neoplastic cells than in normal tissue in experimentally induced bladder tumours in rats (39) . Therefore, it could be suggested that differences in DNA adduct level between tumour and non-tumour larynx tissue may reflect aberrant metabolism and DNA repair in tumour cells.
There are several exogenous and host factors affecting DNA adduct formation in living organisms (40-42). The contribution of some of these has been studied within this work. A strong correlation between cigarette smoking and the level of Nlalkylguanine in tumour and non-tumour larynx tissue of cancer subjects was clearly demonstrated. The number of leucocyte DNA samples from larynx cancer subjects was too small for analysis. However, the average level of A'7-alkylguanine residues in leucocytes of control group I (non-cancer, nonsmokers) was 5.1/10 7 , lower than that (9.7/10 7 ) for control group II (smokers, non-cancer), which, in turn was lower than the value (12.8/10 7 ) for smoking cancer subjects. The level of A'7-alkylguanine was also apparently connected with the subject's sex. In males the average number of A'7-alkylguanine residues exceeded that in females by 3.8-fold in larynx tumour and 1.9-fold in larynx non-tumour tissue. To some extent this reflects differences in larynx cancer morbidity between the sexes, where an at least 10 times higher incidence in males than in females is indicated (5, 6, 8) .
The effect of age was analysed because it has been shown in animal models that DNA alkylation damage increases with Tobacco smoke-associated A r 7-alkylguanlne age, due to declining efficiency of DNA repair (43) (44) (45) . An age-related increase in A^-alkylguanine content in the larynx was seen only in tumour tissue and was not significant.
Hence, exogenous exposure appears to be the most important factor for the actual level of A/7-alkylguanine in larynx cancer subjects. Other factors studied, such as sex and age, seem to play a secondary role in DNA adduct formation.
Inter-individual differences in DNA adduct level have frequently been reported (46) . This is clear if one takes into account genetic polymorphism of enzymes involved in the three main stages of carcinogen processing, i.e. carcinogen activation, detoxification and DNA repair (47) . It seems that DNA adduct distribution in a randomly exposed population reflects the polymorphic character of carcinogen activating enzymes (47, 48) . However, the two groups of genotoxicants present in tobacco smoke which we have considered are metabolized by different activating enzymes. The initial metabolic activation of PAH is mediated by CYP 1A1 (49) , but Nnitrosoamines are activated by CYP 2A6, CYP 2E1 and other cytochrome P450-dependent enzymes (50) encoded by different gene loci (49) . Differences also emerge in DNA repair processing. Aromatic bulky adducts are removed in the course of nucleotide excision repair, while methylated adducts are depurinated or removed by base excision repair (40,51).
Identification of potential factors, other than smoking, responsible for the high incidence of larynx cancer in Poland was outside the remit of the present study. Formation of aromatic DNA adducts in white blood cells of Polish coke oven workers and residents of Upper Silesia (a highly polluted industrial region of Poland) has been described in other papers (52) . However, the Poznari area is relatively unpolluted (53) and the influence of environmental contamination can be considered small.
For a further understanding of the role of tobacco-derived DNA adducts in larynx carcinogenesis it will be of interest to compare the patterns of DNA adducts with mutations induced in oncogenes and anti-oncogenes. Mutations in the p53 gene, including tobacco-induced ones, are already established in larynx cancer subjects and at least some of them are attributable to PAH or /V-nitrosoamine exposure (54) .
